{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:31:14Z","timestamp":1781753474881,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12026-016-8819-5","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T11:21:16Z","timestamp":1468495276000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Adjuvants- and vaccines-induced autoimmunity: animal models"],"prefix":"10.1007","volume":"65","author":[{"given":"Jiram Torres","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Luj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"issue":"4","key":"8819_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity. 2010;33(4):492\u2013503.","journal-title":"Immunity"},{"key":"8819_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","volume":"50","author":"SS Ahmed","year":"2014","unstructured":"Ahmed SS, Schur PH, Macdonald NE, Steinman L, Narcolepsy. A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun. 2014;50:1\u201311.","journal-title":"J Autoimmun"},{"issue":"3","key":"8819_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1006\/jaut.2000.0482","volume":"16","author":"GJ Fournie","year":"2001","unstructured":"Fournie GJ, Mas M, Cautain B, et al. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun. 2001;16(3):319\u201326.","journal-title":"J Autoimmun"},{"key":"8819_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","volume":"100","author":"LE Guimaraes","year":"2015","unstructured":"Guimaraes LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015;100:190\u2013209.","journal-title":"Pharmacol Res"},{"key":"8819_CR5","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.2174\/09298673113209990253","volume":"20","author":"P Cruz-Tapias","year":"2013","unstructured":"Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y. Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)\u2014animal models as a proof of concept. Curr Med Chem. 2013;20:4030\u20136.","journal-title":"Curr Med Chem"},{"key":"8819_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0961203311429818","volume":"21","author":"M Whitehouse","year":"2012","unstructured":"Whitehouse M. Oily adjuvants and autoimmunity: Now time for reconsideration? Lupus. 2012;21:217\u201322.","journal-title":"Lupus"},{"key":"8819_CR7","first-page":"9","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol. 2004;82:9.","journal-title":"Immunol Cell Biol"},{"issue":"11","key":"8819_CR8","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.4049\/jimmunol.179.11.7568","volume":"179","author":"MH Hoffmann","year":"2007","unstructured":"Hoffmann MH, Tuncel J, Skriner K, et al. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis. J Immunol. 2007;179(11):7568\u201376.","journal-title":"J Immunol"},{"key":"8819_CR9","first-page":"2229","volume":"40","author":"M Platica","year":"1980","unstructured":"Platica M, Bojko C, Steiner G, Hollander VP. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth. Cancer Res. 1980;40:2229\u201333.","journal-title":"Cancer Res"},{"key":"8819_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaut.2015.08.009","volume":"65","author":"M Bizjak","year":"2015","unstructured":"Bizjak M, Selmi C, Praprotnik S, et al. Silicone implants and lymphoma: the role of inflammation. J Autoimmun. 2015;65:64\u201373.","journal-title":"J Autoimmun"},{"issue":"2","key":"8819_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12016-010-8212-4","volume":"41","author":"E Israeli","year":"2011","unstructured":"Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease. Clin Rev Allergy Immunol. 2011;41(2):163\u20138.","journal-title":"Clin Rev Allergy Immunol"},{"key":"8819_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/cei.12208","volume":"175","author":"E Favoino","year":"2012","unstructured":"Favoino E, Favia EI, Digiglio L, Racanelli V, Shoenfeld Y, Perosa F. Effects of adjuvants for human use in systemic lupus erythematosus (SLE)-prone (New Zealand black\/New Zealand white) F1 mice. Clin Exp Immunol. 2012;175:32\u201340.","journal-title":"Clin Exp Immunol"},{"key":"8819_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0961203311429556","volume":"21","author":"HF Soldevilla","year":"2012","unstructured":"Soldevilla HF, Briones SFR, Navarra SV. Systemic lupus erythematosus following HPV immunization or infection? Lupus. 2012;21:4.","journal-title":"Lupus"},{"key":"8819_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaut.2014.06.006","volume":"54","author":"N Agmon-Levin","year":"2014","unstructured":"Agmon-Levin N, Arango MT, Kivity S, et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun. 2014;54:21\u201332.","journal-title":"J Autoimmun"},{"key":"8819_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1034\/j.1600-065x.2001.1840117.x","volume":"184","author":"R Holmdahl","year":"2001","unstructured":"Holmdahl R, Lorentzen JC, Lu S, et al. Arthritis induced in rats with non-immunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev. 2001;184:19.","journal-title":"Immunol Rev"},{"key":"8819_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/08830181003746304","volume":"29","author":"S Salemo","year":"2010","unstructured":"Salemo S, D\u2019Amelio R. Could autoimmunity be induced by vaccination? Int Rev Immunol. 2010;29:247\u201369.","journal-title":"Int Rev Immunol"},{"issue":"20","key":"8819_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1001\/jama.1994.03510440062034","volume":"271","author":"KR Stratton","year":"1994","unstructured":"Stratton KR, Howe CJ, Johnston RB Jr. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA. 1994;271(20):1602\u20135.","journal-title":"JAMA"},{"issue":"6","key":"8819_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1006\/jaut.1996.0091","volume":"9","author":"AD Cohen","year":"1996","unstructured":"Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun. 1996;9(6):699\u2013703.","journal-title":"J Autoimmun"},{"issue":"25","key":"8819_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJM199812173392509","volume":"339","author":"AH Ropper","year":"1998","unstructured":"Ropper AH, Victor M. Influenza vaccination and the Guillain\u2013Barr\u00e9 syndrome. N Engl J Med. 1998;339(25):1845\u20136.","journal-title":"N Engl J Med"},{"issue":"7","key":"8819_CR20","first-page":"430","volume":"6","author":"M Tishler","year":"2004","unstructured":"Tishler M, Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J. 2004;6(7):430\u20132.","journal-title":"Isr Med Assoc J"},{"issue":"1\u20132","key":"8819_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaut.2007.11.002","volume":"30","author":"S Praprotnik","year":"2008","unstructured":"Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun. 2008;30(1\u20132):37\u201341.","journal-title":"J Autoimmun"},{"issue":"1","key":"8819_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","volume":"36","author":"Y Shoenfeld","year":"2011","unstructured":"Shoenfeld Y, Agmon-Levin N. ASIA Autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4\u20138.","journal-title":"J Autoimmun"},{"key":"8819_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","volume":"47","author":"C Perricone","year":"2013","unstructured":"Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1\u201316.","journal-title":"J Autoimmun"},{"issue":"7\u20138","key":"8819_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00335-011-9338-2","volume":"22","author":"SW Hall","year":"2011","unstructured":"Hall SW, Cooke A. Autoimmunity and inflammation: murine models and translational studies. Mamm Genome. 2011;22(7\u20138):377\u201389.","journal-title":"Mamm Genome"},{"issue":"3","key":"8819_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12016-007-8049-7","volume":"34","author":"NR Rose","year":"2008","unstructured":"Rose NR. The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol. 2008;34(3):279\u201382.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4014","key":"8819_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.174.4014.1137","volume":"174","author":"AO Vladutiu","year":"1971","unstructured":"Vladutiu AO, Rose N. Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science. 1971;174(4014):1137\u20139.","journal-title":"Science"},{"issue":"2\u20133","key":"8819_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12026-013-8404-0","volume":"56","author":"L Lujan","year":"2013","unstructured":"Lujan L, P\u00e9rez M, Salazar E, et al. Autoimmune\/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep. Immunol Res. 2013;56(2\u20133):317\u201324.","journal-title":"Immunol Res"},{"issue":"4","key":"8819_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0896-8411(03)00136-7","volume":"21","author":"L Wester","year":"2003","unstructured":"Wester L, Olofsson P, Ibrahim SM, Holmdahl R. Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14. J Autoimmun. 2003;21(4):305\u201313.","journal-title":"J Autoimmun"},{"issue":"1","key":"8819_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2249.2004.02498.x","volume":"137","author":"BC Holm","year":"2004","unstructured":"Holm BC, Lorentzen JC, Bucht A. Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset. Clin Exp Immunol. 2004;137(1):59\u201364.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"8819_CR30","doi-asserted-by":"publisher","first-page":"R361","DOI":"10.1186\/ar993","volume":"5","author":"L Wester","year":"2003","unstructured":"Wester L, Koczan D, Holmberg J, et al. Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats. Arthritis Res Ther. 2003;5(6):R361\u201372.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"8819_CR31","first-page":"9","volume":"149","author":"C Vingsbo","year":"1996","unstructured":"Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol. 1996;149(5):9.","journal-title":"Am J Pathol"},{"issue":"9","key":"8819_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","volume":"30","author":"WH Reeves","year":"2009","unstructured":"Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009;30(9):455\u201364.","journal-title":"Trends Immunol"},{"issue":"2","key":"8819_CR33","doi-asserted-by":"publisher","first-page":"e88302","DOI":"10.1371\/journal.pone.0088302","volume":"9","author":"M De Franco","year":"2014","unstructured":"De Franco M, Peters LC, Correa MA, et al. Pristane-induced arthritis loci interact with the Slc11a1 gene to determine susceptibility in mice selected for high inflammation. PLoS ONE. 2014;9(2):e88302.","journal-title":"PLoS ONE"},{"key":"8819_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2567.1996.d01-730.x","volume":"89","author":"RN Barker","year":"1996","unstructured":"Barker RN, Easterfield AJ, Allen RF, Wells AD, Elson CJ, Thompson SJ. B- and T-cell autoantigens in pristane-induced arthritis. Immunology. 1996;89:6.","journal-title":"Immunology"},{"issue":"2","key":"8819_CR35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4049\/jimmunol.176.2.1172","volume":"176","author":"J Holmberg","year":"2006","unstructured":"Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, Holmdahl R. Pristane, a Non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol. 2006;176(2):1172\u20139.","journal-title":"J Immunol"},{"key":"8819_CR36","first-page":"10","volume":"31","author":"R Morgan","year":"2004","unstructured":"Morgan R, Wu B, Song Z, Wooley PH. Immune reactivity to connective tissue antigens in pristane induced arthritis. J Rheumatol. 2004;31:10.","journal-title":"J Rheumatol"},{"issue":"2","key":"8819_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.clim.2014.11.008","volume":"156","author":"W Zhu","year":"2015","unstructured":"Zhu W, Jiang C, Xu J, et al. Pristane primed rat T cells enhance TLR3 expression of fibroblast-like synoviocytes via TNF-alpha initiated p38 MAPK and NF-kappaB pathways. Clin Immunol. 2015;156(2):141\u201353.","journal-title":"Clin Immunol"},{"issue":"3","key":"8819_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2249.1995.tb05558.x","volume":"99","author":"C Vingsbo","year":"1995","unstructured":"Vingsbo C, Sahistrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol. 1995;99(3):359\u201363.","journal-title":"Clin Exp Immunol"},{"key":"8819_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1084\/jem.159.5.1388","volume":"159","author":"N Kaibara","year":"1984","unstructured":"Kaibara N, Hotokebuchi T, Takagishi K, et al. Pathogenic difference between collagen arthritis and adjuvant arthritis. J Exp Med. 1984;159:9.","journal-title":"J Exp Med"},{"issue":"1","key":"8819_CR40","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.4049\/jimmunol.151.9.5081","volume":"151","author":"LG Ratkay","year":"1993","unstructured":"Ratkay LG, Zhang L, Tonzetich J, Waterfield JD. Complete Freund\u2019s adjuvant induces an earlier and more severe arthritis in MRL-ipr mice. J Immunol. 1993;151(1):5081\u20137.","journal-title":"J Immunol"},{"issue":"2","key":"8819_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2249.1994.tb06554.x","volume":"96","author":"S Kleinau","year":"1994","unstructured":"Kleinau S, Erlandsson H, Klareskog L. Percutaneous exposure of adjuvant oil causes arthritis in DA rats. Clin Exp Immunol. 1994;96(2):281\u20134.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"8819_CR42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1365-2567.1997.00251.x","volume":"91","author":"L Svelander","year":"1994","unstructured":"Svelander L, M\u00fcssener A, Erlandsson-Harris H, Kleinau S. Polyclonal Thl cells transfer oil-induced arthritis. Immunology. 1994;91(2):260\u20135.","journal-title":"Immunology"},{"key":"8819_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1073\/pnas.95.11.6383","volume":"95","author":"JC Lorentzen","year":"1998","unstructured":"Lorentzen JC, Glaser A, Jacobsson L, et al. Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci USA. 1998;95:5.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"8819_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/hmg\/10.6.565","volume":"10","author":"BC Holm","year":"2001","unstructured":"Holm BC, Xu HW, Jacobsson L, Larsson A, Luthman H, Lorentzen J. Rats made congenic for Oia3 on chromosome 10 become susceptible to squalene-induced arthritis. Hum Mol Gen. 2001;10(6):565\u201372.","journal-title":"Hum Mol Gen"},{"key":"8819_CR45","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/S0002-9440(10)65077-8","volume":"156","author":"BC Carlson","year":"2000","unstructured":"Carlson BC, Jansson AM, Larsson A, Bucht A, Lorentzen JC. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Am J Pathol. 2000;156:2057\u201365.","journal-title":"Am J Pathol"},{"key":"8819_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01276.x","volume":"121","author":"M Satoh","year":"2000","unstructured":"Satoh M, Richards HB, Shaheen VM, et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol. 2000;121:399\u2013405.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8819_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1084\/jem.188.5.985","volume":"188","author":"HB Richards","year":"1998","unstructured":"Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med. 1998;188(5):6.","journal-title":"J Exp Med"},{"issue":"24","key":"8819_CR48","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1073\/pnas.92.24.10934","volume":"92","author":"M Satoh","year":"1995","unstructured":"Satoh M, Kumar A, Kanwar YS, Reeves WH. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB\/c mice treated with pristane. Proc Natl Acad Sci USA. 1995;92(24):10934\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"8819_CR49","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/eji.201141642","volume":"42","author":"D Feng","year":"2012","unstructured":"Feng D, Yang L, Bi X, Stone RC, Patel P, Barnes BJ. Protection of Irf5-deficient mice from pristane-induced lupus involves altered cytokine production and class switching. Eur J Immunol. 2012;42(6):1477\u201387.","journal-title":"Eur J Immunol"},{"issue":"3","key":"8819_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1365-2249.1999.00825.x","volume":"115","author":"HB Richards","year":"1999","unstructured":"Richards HB, Satoh M, Jennette JC, Okano T, Kanwar YS, Reeves WH. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Clin Exp Immunol. 1999;115(3):547\u201353.","journal-title":"Clin Exp Immunol"},{"key":"8819_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/271694","volume":"2011","author":"D Perry","year":"2011","unstructured":"Perry D, Sang A, Yin Y, Zheng YY, Morel L. Murine models of systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:1\u201319.","journal-title":"J Biomed Biotechnol"},{"key":"8819_CR52","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cei.12287","volume":"176","author":"SA Summers","year":"2014","unstructured":"Summers SA, Odobasic D, Khouri MB, et al. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane. Clin Exp Immunol. 2014;176:342\u201350.","journal-title":"Clin Exp Immunol"},{"key":"8819_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1365-2249.2005.02847.x","volume":"141","author":"R Clynes","year":"2005","unstructured":"Clynes R, Calvani N, Croker PB, Richards HB. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clin Exp Immunol. 2005;141:230\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"8819_CR54","first-page":"251","volume":"32","author":"H Bagavant","year":"2014","unstructured":"Bagavant H, Nandula SR, Kaplonek P, Rybakowska PD, Deshmukh US. Alum, an aluminium based adjuvant, induces Sj\u00f6gren\u2019s syndrome-like disorder in mice. Clin Exp Rheumatol. 2014;32(2):251\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"8819_CR55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/iai.49.1.40-45.1985","volume":"49","author":"YC Kong","year":"1985","unstructured":"Kong YC, Audibert F, Giraldo AA, Rose NR, Chedid L. Effects of natural or synthetic microbial adjuvants on induction of autoimmune thyroiditis. Infect Immun. 1985;49:40\u20135.","journal-title":"Infect Immun"},{"issue":"6","key":"8819_CR56","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1172\/JCI0212337","volume":"109","author":"M Blank","year":"2002","unstructured":"Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to \u03b22-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002;109(6):797\u2013804.","journal-title":"J Clin Invest"},{"issue":"5","key":"8819_CR57","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1600-0897.2010.00922.x","volume":"65","author":"I Zivkovic","year":"2011","unstructured":"Zivkovic I, Stojanovic M, Petrusic V, Inic-Kanada A, Dimitrijevic L. Induction of APS after TTd hyper-immunization has a different outcome in BALB\/c and C57BL\/6 mice. Am J Reprod Immunol. 2011;65(5):492\u2013502.","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"8819_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1071\/RD13057","volume":"26","author":"V Petrusic","year":"2014","unstructured":"Petrusic V, Zivkovic I, Muhandes L, Dimitrijevic R, Stojanovic M, Dimitrijevic L. Infection-induced autoantibodies and pregnancy related pathology: an animal model. Reprod Fertil Dev. 2014;26(4):578\u201386.","journal-title":"Reprod Fertil Dev"},{"issue":"2","key":"8819_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/08916934.2014.961061","volume":"48","author":"V Petrusic","year":"2015","unstructured":"Petrusic V, Todorovic N, Zivkovic I, et al. Autoantibody response and pregnancy-related pathology induced by combined LPS and tetanus toxoid hyperimmunization in BALB\/c and C57BL\/6 mice. Autoimmunity. 2015;48(2):87\u201399.","journal-title":"Autoimmunity"},{"issue":"7","key":"8819_CR60","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.4049\/jimmunol.181.7.4807","volume":"181","author":"EO Koppang","year":"2008","unstructured":"Koppang EO, Bjerkas I, Haugarvoll E, et al. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J Immunol. 2008;181(7):4807\u201314.","journal-title":"J Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-016-8819-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8819-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:19:16Z","timestamp":1692425956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-016-8819-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8819"],"URL":"https:\/\/doi.org\/10.1007\/s12026-016-8819-5","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]},"assertion":[{"value":"14 July 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}